Robert Tjian
Co-Founder & Member of Scientific Advisory BoardDr. Robert Tjian, also known as Tij, Ph.D. serves as Advisor at Bevc Management, Llc. He co-founded Eikon Therapeutics, Inc. in July 2019 and serves as its Member of Scientific Advisory Board. He serves as Scientific Founder at Lyterian Therapeutics, Inc. He served as Member of Scientific Advisory Board of Research Trends & Emerging Technologies at Amgen Inc. until 2026. Dr. Tjian serves as Discovery Partner of The Column Group since September 2016. Dr. Tjian served as a Director of Neurona Therapeutics Inc. Dr. Tjian serves as Scientific Advisor to the Chan Zuckerberg Initiative and the BioHub. He serves as a Faculty of University of California, Berkeley since joining in 1979, where he assumed several leadership roles including Director of the Berkeley Stem Cell Center, faculty Director of the Li Ka Shing Center for Biomedical and Health Sciences and Head of the Siebel Stem Institute. He served as the President of Howard Hughes Medical Institute (HHMI) since April 1, 2009 to September 2016. He was an Investigator of the Howard Hughes Medical Institute since 1987. He co-founded Tularik, Inc. in 1991. He serves as Co-Chairman of the Board of Directors of Bio Online, Inc. He served as Director of Escient Pharmaceuticals Inc. He was the Chairman of Scientific Advisory Board at Nurix Therapeutics, Inc. since November 1, 2020 until 2021. He was a Director at Nurix Therapeutics, Inc. (formerly known as Nurix Inc.) since November 2016 until November 1, 2020. He serves as a Member of Scientific Advisory Board of KAI Pharmaceuticals, Inc. He serves as a Member of the National Academy of Sciences. He served as Member of the Scientific Advisory Board at Constellation Pharmaceuticals, Inc. Dr. Tjian currently holds the Li Ka Shing Chancellor Chair in Biology at the University of California, Berkeley. He served as a Member of Scientific Advisory Board at Five Prime Therapeutics, Inc. His several distinguished scientific societies include: the Academia Sinica of China (1990), the National Academy of Sciences of the United States in 1991 and the American Academy of Arts and Sciences in 1997. Dr. Tjian is one of the pioneers in the elucidation of the molecular mechanism of transcriptional regulation in higher organisms. He discovered over 75 protein factors that work in concert to regulate gene expression. Dr. Tjian also discovered the first transcription factors, human proteins that bind to specific sections of DNA. Dr. Tjian’s research has focused on key transcription events in embryonic stem cells. He received numerous awards and distinctions, including the Pfizer Award for Enzymology in 1987, the 1988 Cancer Research Award from the Milken Family Medical Foundation and the National Academy of Sciences Monsanto Award for Molecular Biology in 1991. In 1994, he was the California Scientist. Dr. Tjian received The Passano Award for Biological Sciences and the Rosenstiel Award for Distinguished Work in Basic Medical Science in 1995. In 1999, he was honored with the General Motors Alfred P. Sloan Jr. Prize and he won the Louisa Gross Horwitz Prize from Columbia University. Throughout his studies have combined Biochemistry, Molecular Biology, Genetics and Structural Biology to dissect the structure and function of the eukaryotic transcriptional apparatus. He holds Doctorate from Harvard University.
Positions
- Company NameEikon Therapeutics, Inc.Stock CodeEIKNPositionCo-Founder & Member of Scientific Advisory Board
